Company: ZVRA
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001628280-25-039967
Chunk: 131

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 8
Chunk 131
---
 quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and•Level 3: Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.The carrying amounts of certain financial instruments, including cash and cash equivalents, accounts and other receivables, and accounts payable and accrued expenses approximate their respective fair values due to the short-term nature of such instruments.Assets and Liabilities Measured at Fair Value on a Recurring BasisThe Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level in which to classify them for each reporting period. This determination requires significant judgments to be made. The following table summarizes the conclusions reached regarding fair value measurements as of June 30, 2025, and December 31, 2024 (in thousands):Balance as of June 30, 2025Quoted Prices in ActiveMarkets for Identical Assets(Level 1)Significant Other ObservableInputs (Level 2)Significant UnobservableInputs (Level 3)CVR liability$1,370 $— $— $1,370 Warrant liabilities15,807 — — 15,807 Total liabilities$17,177 $— $— $17,177 Securities:U.S. Treasury securities$124,715 $124,715 $— $— Corporate bonds45,273 — 45,273 — Total assets$169,988 $124,715 $45,273 $— Balance as of December 31, 2024Quoted Prices in ActiveMarkets for Identical Assets(Level 1)Significant Other ObservableInputs (Level 2)Significant UnobservableInputs (Level 3)CVR liability$3,500 $— $— $3,500 Warrant liabilities17,804 — — 17,804 Total liabilities$21,304 $— $— $21,304 Securities:U.S. Treasury securities$35,711 $35,711 $— $— Corporate bonds6,010 — 6,010 — Total assets$41,721 $35,711 $6,010 $— 

22

WarrantsThe common stock warrant liabilities were recorded at fair value using the BSM option pricing